Absorption |
Blood-Brain Barrier | BBB+ | 0.9379 |
Human Intestinal Absorption | HIA+ | 0.9848 |
Caco-2 Permeability | Caco2+ | 0.6363 |
P-glycoprotein Substrate | Non-substrate | 0.8744 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9827 |
Non-inhibitor | 0.9864 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9215 |
Distribution |
Subcellular localization | Lysosome | 0.7163 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8630 |
CYP450 2D6 Substrate | Non-substrate | 0.8177 |
CYP450 3A4 Substrate | Non-substrate | 0.8359 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8817 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8047 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9388 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9009 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9625 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6464 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9573 |
Non-inhibitor | 0.9635 |
AMES Toxicity | Non AMES toxic | 0.9385 |
Carcinogens | Carcinogens | 0.5973 |
Fish Toxicity | High FHMT | 0.6239 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.8383 |
Honey Bee Toxicity | High HBT | 0.7765 |
Biodegradation | Not ready biodegradable | 0.6407 |
Acute Oral Toxicity | III | 0.4913 |
Carcinogenicity (Three-class) | Non-required | 0.6574 |